---
title: "Scienture surges 11% after-hours after Q2 revenue jumps 510% and second product launch"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295975431.md"
description: "Scienture rose 11% after-hours to $0.45 as it reported Q2 revenue up 510% to $343,600 and launched its second commercial product."
datetime: "2026-08-14T20:51:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295975431.md)
  - [en](https://longbridge.com/en/news/295975431.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295975431.md)
generator: "portal-rs"
---

# Scienture surges 11% after-hours after Q2 revenue jumps 510% and second product launch

Scienture(SCNX.US) 盘后时段涨超**11%**，现报**0.4531 美元**。

公司近期公布 2026 年第二季度业绩，营收环比增长**510%**至**34.36 万美元**，毛利率达**97.7%**，运营亏损和净亏损同比分别收窄**48%**和**58%**，现金储备增至**1120 万美元**。公司同期推出第二款商用产品 REZENOPY™（10 毫克纳洛酮鼻喷剂），为美国获批的最高剂量阿片类药物过量急救鼻喷剂，并完成了首批批发订单发货。此外，公司宣布获得 REZENOPY™美国专利，知识产权保护期延长至 2041 年，同时 Arbli™的支付方覆盖范围进一步扩大。

### Related Stocks

- [SCNX.US](https://longbridge.com/en/quote/SCNX.US.md)

## Related News & Research

- [EXCLUSIVE: Scienture Expands Institutional Reach for Hypertension Drug with New Hospital Adoptions](https://longbridge.com/en/news/300788428.md)
- [SCNX: Rapid revenue growth and FDA-approved launches highlight a strong specialty pharma pipeline](https://longbridge.com/en/news/298957496.md)
- [TECHNICALS-US oil may retest support at $88.78](https://longbridge.com/en/news/300892493.md)
- [Saudi Arabia unexpectedly cuts oil prices to Asia](https://longbridge.com/en/news/300887141.md)
- [Greg Abel-Led Berkshire Hathaway Owns 3 Consumer Stocks. Here's the One I'd Buy First.](https://longbridge.com/en/news/300873098.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**